Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis.
Hennenberg M, Trebicka J, Kohistani Z, Stark C, Nischalke HD, Krämer B, Körner C, Klein S, Granzow M, Fischer HP, Heller J, Sauerbruch T.
Hennenberg M, et al.
Lab Invest. 2011 Feb;91(2):241-51. doi: 10.1038/labinvest.2010.148. Epub 2010 Oct 4.
Lab Invest. 2011.
PMID: 20921950
Free article.